Key result
Web-based nomogram achieves a 0.913 C-index predicting cancer-specific survival in elderly surgical prostate cancer patients.
Why the study?
The impact of surgery on the prognosis of elderly prostate cancer patients is controversial, and no predictive models exist to predict their prognosis.
Does a nomogram based on clinical and pathological factors accurately predict cancer-specific survival in elderly prostate cancer patients undergoing surgical treatment?
Observational (n=44,975)
Yes
Does a nomogram based on clinical and pathological factors accurately predict cancer-specific survival in elderly prostate cancer patients undergoing surgical treatment?
A newly developed nomogram incorporating age, TNM stage, surgical method, PSA, and Gleason score accurately predicts 3-, 5-, and 8-year cancer-specific survival in elderly prostate cancer patients undergoing surgery.
May inform prognosis discussions for elderly prostate cancer surgery patients; leaves open external validation in diverse cohorts.
Objective: Prostate cancer (PC) is the second leading cause of cancer death in men in the United States after lung cancer in global incidence. Elderly male patients over 65 years old account for more than 60% of PC patients, and the impact of surgical treatment on the prognosis of PC patients is controversial. Moreover, there are currently no predictive models that can predict the prognosis of elderly PC patients undergoing surgical treatment. Therefore, we aimed to construct a new nomogram to predict cancer-specific survival (CSS) in elderly PC patients undergoing surgical treatment. Methods: Data for surgically treated PC patients aged 65 years and older were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox regression models were used to identify independent risk factors for elderly PC patients undergoing surgical treatment. A nomogram of elderly PC patients undergoing surgical treatment was developed based on the multivariate Cox regression model. The consistency index (C-index), the area under the subject operating characteristic curve (AUC), and the calibration curve were used to test the accuracy and discrimination of the predictive model. Decision curve analysis (DCA) was used to examine the potential clinical value of this model. Results: = 13270). the training set was used for nomogram development and the validation set was used for internal validation. Univariate and multivariate Cox regression model analysis showed that age, marriage, TNM stage, surgical style, chemotherapy, radiotherapy, Gleason score(GS), and prostate-specific antigen(PSA) were independent risk factors for CSS in elderly PC patients undergoing surgical treatment. The C index of the training set and validation indices are 0.911(95%CI: 0.899-0.923) and 0.913(95%CI: 0.893-0.933), respectively, indicating that the nomogram has a good discrimination ability. The AUC and the calibration curves also show good accuracy and discriminability. Conclusions: To our knowledge, our nomogram is the first predictive model for elderly PC patients undergoing surgical treatment, filling the gap in current predictive models for this PC patient population. Our data comes from the SEER database, which is trustworthy and reliable. Moreover, our model has been internally validated in the validation set using the C-index,AUC and the and the calibration curve, showed that the model have good accuracy and reliability, which can help clinicians and patients make better clinical decision-making. Moreover, the DCA results show that our nomogram has a better potential clinical application value than the TNM staging system.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) conducted an observational in Prostate cancer (n=44,975). Web-based prediction model (nomogram) vs. TNM staging system was evaluated on Model discrimination (C-index) for cancer-specific survival in the validation set (95% CI 0.893-0.933). A web-based nomogram accurately predicted cancer-specific survival in elderly prostate cancer patients undergoing surgery, achieving a C-index of 0.913 in the validation cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: